Next Article in Journal
Characterization of Potent ABCG2 Inhibitor Derived from Chromone: From the Mechanism of Inhibition to Human Extracellular Vesicles for Drug Delivery
Next Article in Special Issue
Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine
Previous Article in Journal
Comparison of Compartmental and Non-Compartmental Analysis to Detect Biopharmaceutical Similarity of Intravenous Nanomaterial-Based Rifabutin Formulations
Previous Article in Special Issue
Computational Modeling on Drugs Effects for Left Ventricle in Cardiomyopathy Disease
 
 
Review

Article Versions Notes

Pharmaceutics 2023, 15(4), 1260; https://doi.org/10.3390/pharmaceutics15041260
Action Date Notes Link
article xml file uploaded 17 April 2023 13:11 CEST Original file -
article xml uploaded. 17 April 2023 13:11 CEST Update -
article pdf uploaded. 17 April 2023 13:11 CEST Version of Record https://www.mdpi.com/1999-4923/15/4/1260/pdf-vor
article html file updated 17 April 2023 13:13 CEST Original file -
article xml file uploaded 18 April 2023 02:32 CEST Update -
article xml uploaded. 18 April 2023 02:32 CEST Update -
article pdf uploaded. 18 April 2023 02:32 CEST Updated version of record https://www.mdpi.com/1999-4923/15/4/1260/pdf-vor
article html file updated 18 April 2023 02:34 CEST Update -
article pdf uploaded. 18 April 2023 04:12 CEST Updated version of record https://www.mdpi.com/1999-4923/15/4/1260/pdf-vor
article html file updated 18 April 2023 04:14 CEST Update -
article xml file uploaded 18 April 2023 04:23 CEST Update -
article xml uploaded. 18 April 2023 04:23 CEST Update https://www.mdpi.com/1999-4923/15/4/1260/xml
article pdf uploaded. 18 April 2023 04:23 CEST Updated version of record https://www.mdpi.com/1999-4923/15/4/1260/pdf
article html file updated 18 April 2023 04:24 CEST Update https://www.mdpi.com/1999-4923/15/4/1260/html
Back to TopTop